The initiative focused on border communities, refugee camps, and other vulnerable areas where frequent cross-border movement increases the risk of disease transmission.
The agreement gives Apollo-managed funds and affiliates a non-controlling interest in a newly created entity that will hold Bayer’s LARC portfolio.
MindRank developed MAP as an AI-native drug discovery engine that combines computational biology, chemistry, laboratory experiments and clinical data into a single research platform.
The investment will fund the construction of a new 500,000-square-foot manufacturing facility, along with extensive upgrades to the company’s existing 700,000-square-foot plant in Austin, Texas.
Arprim Consultants presented a master plan and feasibility study led by Principal Architect Jared Momanyi, which sets out a phased approach to meet rising regional healthcare needs.
The ministry and Samsung is exploring plans to establish a state-of-the-art training facility equipped with advanced technologies that can support the practical training of healthcare professionals.
The approval allows laboratories across Europe and other CE-recognising markets to use the assay to support the clinical evaluation of amyloid pathology in people showing signs of cognitive decline.
Evonik will use the funding to upgrade major production assets, including large reactors and other critical processing systems.
Under the agreement, researchers will gain access to an integrated platform that combines Evogene’s AI-powered computational chemistry engine, ChemPass AI, with the BCDD’s laboratory infrastructure and drug discovery expertise.
Philips developed Alturion to simplify routine ultrasound examinations without compromising image quality.